US FDA approves AbbVie’s drug for Parkinson’s disease
The US Food and Drug Administration has approved AbbVie’s drug for Parkinson’s disease in adults, the health regulator’s website showed on Friday.
The US Food and Drug Administration has approved AbbVie’s drug for Parkinson’s disease in adults, the health regulator’s website showed on Friday.